MedTrace Logo

Pan-Canadian Lung Cancer Observational Study (PALEOS)

NCT04706754 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2025-08-01

No results posted yet for this study

Summary

A multicenter, ambispective observational study focusing on patients diagnosed with lung cancer in Canada identified after January 1, 2000 inclusive. This data will be combined with that from deceased patients identified.

Conditions

Interventions

OTHER

Questionnaires

Participants will complete the survey(s) at the initial visit and every 3 months and/or whenever there is an update in their treatment protocol. Patients may also choose to opt out of the surveys and only consent to primary data collection at the site.

Sponsors & Collaborators

  • Pulse Infoframe

    collaborator INDUSTRY

  • William Osler Health System

    lead OTHER

Principal Investigators

  • Parneet Cheema, MD · William Osler Health System

  • Sara Kuruvilla, MD · London Health Science Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-07
Primary Completion
2040-04-07
Completion
2045-04-07

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04706754 on ClinicalTrials.gov